Stock Chart
ASMB
Type: SELL wallstreet
Strike: $40
Premium: $8.50
Expiry: Jun 18, 2026
Target: $40
Score: -95
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ASMB - Assembly Biosciences, Inc
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has …
Key Statistics
More ASMB Analysis
This ASMB stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ASMB's price movements with trendlines, gamma walls, and key support/resistance levels.